Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
An evaluation of the effectiveness of structured Cognitive Behaviour Therapy (CBT) self-help materials delivered by a self-help support worker within primary care
ISRCTN ISRCTN13475030
ClinicalTrials.gov identifier
Public title An evaluation of the effectiveness of structured Cognitive Behaviour Therapy (CBT) self-help materials delivered by a self-help support worker within primary care
Scientific title
Acronym N/A
Serial number at source 04 AMO6
Study hypothesis 1. Patients using the CBT self-help materials will have:
1.1. Improved mood measured on the Beck Depression Inventory (BDI-II)
1.2. Improved social functioning measured on the Clinical Outcome Measure in Routine evaluation - Outcome Measure (CORE-OM)
1.3. Lower health care costs
1.4. Improved knowledge of the causes and treatment of depression compared to the control group receiving treatment as usual
2. Written self-help will be acceptable to both patients and staff within a primary care setting
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Depressive symptoms
Participants - inclusion criteria 1. Patients presenting in a primary care/General Practice setting with symptoms of depression
2. Beck Depression Inventory -II score of 14 or more
3. Aged eighteen or above
4. Able to use the materials (i.e. have no visual or reading problems, learning difficulties or dementia)
Any member of the primary care team including GPs, practice or district nurses and health visitors will be able to refer to the study.
Participants - exclusion criteria 1, Suicidal intent (score of 2 or more on the BDI-II suicidal thoughts item)
2. Impaired concentration and motivation (as measured by a score of 7 or more on the combined BDI II items for energy [item 15], concentration difficulty [item 19] and tiredness [item 20])
Anticipated start date 01/04/2004
Anticipated end date 30/06/2007
Status of trial Completed
Patient information material
Target number of participants 100 evaluable patients in each arm i.e. 200 evaluable patients
Interventions We are evaluating a structured self-help workbook treatment for mild to moderate depression called Overcoming Depression: A Five Areas Approach. A randomised controlled study design comparing treatment as usual as a control (arm 1); and supported self-help via three 40-minute appointments at week 1, 2 and one month (the '2 + 1' model, Barkham et al, 1996) comprising the second arm of the study.
Primary outcome measure(s) Comparison between the Beck Depression Inventory -II scores for the two randomised groups (self help plus treatment as usual versus TAU) using a 2 sample 2-sided t-test at 4 months.
Secondary outcome measure(s) Psychological symptoms, well-being, risk and social functioning (using the CORE-OM scale), and acceptability of the intervention (using the Client Satisfaction Questionnaire- CSQ) compared to treatment as usual. In addition, the health care costs of both arms are being evaluated and the Euroquol (European Quality of Life measure) used to record health status and health-related quality of life change. Secondary analyses will also examine the impact of treatment patient knowledge. Further analyses that adjust the treatment effect for a pre-specified set of baseline covariates thought to be of influence on the treatment effect such as use of antidepressants, other self-help materials, and the chronicity of depression using Normal Linear models, will be considered. The approach by Jacobson et al, (1991) to present change in the group under study at the level of the individual will also be used. Categorical data will be compared between the two groups using chi-squared tests and logistic regression to adjust for covariates.
Sources of funding Chief Scientists Office Scottish Executive Health Department (UK) (ref: CZH/4/61)
Trial website
Publications
Contact name Dr  Christopher  Williams
  Address Psychological Medicine
Gartnavel Royal Hospital
1055 Great Western Road
  City/town Glasgow
  Zip/Postcode G63 9SJ
  Country United Kingdom
  Tel +44 (0)141 2113912
  Email chris.williams@clinmed.gla.ac.uk
Sponsor NHS Greater Glasgow (UK)
  Address Research Manager
Research and Development Directorate
Gartnavel Royal Hospital
1055 Great Western Road
  City/town Glasgow
  Zip/Postcode G12 0XH
  Country United Kingdom
  Tel +44 (0)141 211 3661
  Fax +44 (0)141 2113814
  Email brian.rae@gartnavel.glacomen.scot.nhs.uk
Date applied 30/08/2005
Last edited 22/09/2009
Date ISRCTN assigned 09/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central